BRIEF published on 04/16/2025 at 07:05, 11 months 11 days ago Innate Pharma General Meeting Announced for May 22, 2025 Shareholders Biotechnology General Meeting Innate Pharma Marseille
PRESS RELEASE published on 04/16/2025 at 07:00, 11 months 11 days ago Informations privilégiées / Autres communiqués L'assemblée générale annuelle d'Innate Pharma aura lieu le 22 mai 2025 à Marseille. Informations disponibles pour les actionnaires en ligne ou sur demande. Détails sur les traitements contre le cancer Biotechnologie Assemblée Générale Traitement Cancer Innate Pharma
BRIEF published on 04/03/2025 at 13:24, 11 months 24 days ago Innate Pharma participe au Stifel 2025 Virtual Targeted Oncology Forum Euronext Paris Immunothérapie Oncologie Innate Pharma Forum Virtuel
BRIEF published on 04/03/2025 at 13:24, 11 months 24 days ago Innate Pharma participates in the Stifel 2025 Virtual Targeted Oncology Forum Euronext Paris Oncology Immunotherapy Innate Pharma Virtual Forum
PRESS RELEASE published on 04/03/2025 at 13:19, 11 months 24 days ago INFORMATIONS PRIVILÉGIÉES / AUTRES COMMUNIQUÉS Innate Pharma annonce sa participation au Stifel 2025 Virtual Targeted Oncology Forum. Présentation prévue le 9 avril 2025. Informations sur les traitements innovants contre le cancer Immunothérapie Cancer Oncologie Innate Pharma Stifel 2025
BRIEF published on 04/03/2025 at 13:18, 11 months 24 days ago Innate Pharma to Engage in Stifel 2025 Virtual Oncology Forum Biotechnology Immunotherapy Virtual Event Innate Pharma Oncology Forum 2025
BRIEF published on 04/03/2025 at 13:18, 11 months 24 days ago Innate Pharma participera au forum virtuel d'oncologie Stifel 2025 Biotechnologie Immunothérapie Événement Virtuel Innate Pharma Forum D'oncologie 2025
PRESS RELEASE published on 04/03/2025 at 13:13, 11 months 24 days ago INSIDE INFORMATION / OTHER NEWS RELEASES Innate Pharma to participate in 2025 Stifel Virtual Targeted Oncology Forum. Executive team presenting and hosting 1x1 meetings. Focus on innovative cancer immunotherapies Cancer Innate Pharma Immunothérapies Stifel Targeted Oncology Forum
PRESS RELEASE published on 03/28/2025 at 14:37, 11 months 30 days ago Annual financial and audit reports / Annual financial report
PRESS RELEASE published on 03/28/2025 at 14:32, 11 months 30 days ago Rapports financiers et d'audit annuels / Rapport financier annuel
Published on 03/27/2026 at 12:30, 3 hours 2 minutes ago Pasinex Closes First Tranche of Over-Subscribed Non-Brokered Private Placement
Published on 03/27/2026 at 12:00, 3 hours 32 minutes ago Temas Appoints Scientific Advisory Board to Accelerate RCL Commercialisation and Global Development
Published on 03/27/2026 at 11:00, 4 hours 32 minutes ago RE Royalties Announces Strategic Review to Evaluate Path for Long-Term Value Creation
Published on 03/27/2026 at 09:30, 6 hours 2 minutes ago Amap Street Stars Launches Macao Authentic Delicacies Ranking to Drive Cultural-Tourism Innovation in the Greater Bay Area
Published on 03/27/2026 at 15:05, 27 minutes ago Huawei's 6th Global Installer Summit: Gathering the Best Installers to Embrace Renewable Energy Opportunities in the AI Era
Published on 03/27/2026 at 14:31, 1 hour 1 minute ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 03/27/2026 at 14:30, 1 hour 2 minutes ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 03/27/2026 at 14:29, 1 hour 3 minutes ago Form 8.3 - The Vanguard Group, Inc.: AEW UK REIT plc
Published on 03/27/2026 at 07:00, 8 hours 32 minutes ago WEB SA - CONVOCATION ASSEMBLEE GENERALE ORDINAIRE EXERCICE 2025 - 28/04/2026
Published on 03/26/2026 at 18:17, 21 hours 15 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 21 hours 15 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 21 hours 32 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
